Cardiff and Vale University Health Board

Cardiff, Wales CF14 4XW

0 studies enrolling now · 2 studies all time

What they study most

Critical Illness, Enteral Feeding Intolerance, Enteral Nutrition, Hematopoietic Stem Cells

Studies at this site

• Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation — Completed
• TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI) — Stopped early